Agents Used in Cardiac Arrhythmias

by Mukhtar, Sumbal

Pharmacology

Your browser is too old

We can't provide a great video experience on old browser

Update now
Data 2fimages 2fseyhgzwztamzugp3wleg 181027 s0 mukhtar sumbal agents used in cardiac arrythmias intro
04:16
Agents Used in Cardiac Arrhythmias
Data 2fimages 2fodzezsslr5606y4lqcgg 181027 s1 mukhtar sumbal arrhythmias
15:12
Arrhythmias
Data 2fimages 2fimhanf4cs9sjlfhbylgo 181027 s2 mukhtar sumbal sodium channel blocking agents
08:38
Sodium Channel Blocking Agents
Data 2fimages 2f5gtqf9sesvk50t7akb15 181027 s3 mukhtar sumbal subgroup 1a and 1b
10:31
Subgroup 1A and 1B
Data 2fimages 2fz3rkzaxcstyyy7eqnn05 181027 s4 mukhtar sumbal subgroup 1b and 1c
12:17
Subgroup 1B and 1C
Data 2fimages 2fswgfsnkqqymfadhmsvky 181027 s5 mukhtar sumbal class 3 and class 4
08:02
Class 3 and Class 4

Lecture´s Description

Arrhythmias
This lecture presents detailed information on Agents Used in Cardiac Arrhythmias. Section one is primarily focused on the topic of Arrhythmias. The educator starts off with an Overview of Cardiac Arrhythmias and describes the Electrophysiology - Cardiac Rhythm. Furthermore, the Mechanisms of Arrhythmias are clarified to ensure clear understanding. The educator then progresses forward to highlight Classification and Basic Pharmacology of Antiarrhythmic Agents. Apart from this, Specific Antiarrhythmic Agents are also discussed.


Sodium Channel Blocking Agents
Section two elaborates on Sodium Channel Blocking Agents. The educator gives a comprehensive overview of the drug Procainamide. It’s Extracardiac Effects and Toxicity are demonstrated followed by an elucidation of Other ADRs. Moving forward, the Pharmacokinetics of Procainamide are brought under consideration. At the end of this section, the educator reports Dosage of Procainamide and discusses its Therapeutic Use.


Subgroup 1A and 1B
In section three, the educator discusses Subgroup 1A and 1B of Agents Used in Cardiac Arrhythmias. Firstly, the educator puts forth a description of the drug Quinidine. After this, its Pharmacokinetics & Therapeutic Use are brought to light. In addition to this, light is shed on Disopyramide. The Pharmacokinetics & Dosage of Disopyramide are highlighted. Moving forward, information is given regarding Lidocaine - Cardiac Effects. Subsequently, the Toxicity plus Pharmacokinetics & Dosage of Lidocaine are explained.


Subgroup 1B and 1C
Section four is regarding Subgroup 1B and 1C of Agents Used in Cardiac Arrhythmias. In the start, a comprehensive overview of Subgroup 1B is presented which is followed by an elucidation of the drug Mexiletine (Subgroup 1B). Afterwards, a detailed demonstration of Subgroup 1C takes place. To provide a better insight, the educator speaks in detail about Flecainide (Subgroup 1C) and Propafenone. Apart from this, light is shed on Beta Adrenoceptor Blocking Drugs (Class 2). Later, the educator reports Class 3 Drugs and speaks about their Therapeutic Uses plus Toxicity. At the end of this section, information is imparted regarding the drug Dronedarone.


Class 3 and Class 4
The prime focus of section 5 is Class 3 and Class 4 of Agents Used in Cardiac Arrhythmias. In this section, the educator deals with the elucidation of the drugs Sotalol, Dofetilide, and Ibutilide in the beginning. Later, the discussion shifts towards Verapamil (Class 4). After putting forth a thorough overview of Verapamil (Class 4), the educator sheds light on its Therapeutic Uses. Subsequently, various Miscellaneous Antiarrhythmic Agents are discussed followed by the elucidation of drug Diltiazem.

Studies have shown that V-Learning™ increases student's learning and passing rate Significantly.

Studies have shown that V-Learning™ increases student's learning and passing rate Significantly.

100% satisfaction guaranteed, join us & boost your medical Knowledge